Curative Health Services to Hold Third Quarter Conference Call.

Business Editors

ST. LOUIS PARK, Minn.--(BUSINESS WIRE)--Oct. 25, 2001

Curative Health Services, Inc. (Nasdaq: CURE) will hold a conference call to discuss the Company's third quarter 2001 results on Tuesday, October 30, at 10:00 a.m. Central Standard Time (11:00 a.m. Eastern Standard Time).

The third quarter results will be announced on Tuesday, October 30, 2001 prior to the market opening.

To participate in the conference call, dial 1-800-997-8642 approximately 10 minutes prior to the scheduled start time. If you are unable to participate, a digital replay of the call will be available from Tuesday, October 30 at 12:00 p.m. CST (1:00 p.m. EST) until 9:00 p.m. CST on November 6th by dialing 1-800-428-6051 and using confirmation code # 214688.

The live broadcast of Curative Health Services quarterly conference call will be available online by going to www.curative.com and selecting the investor relations link, or by going to www.streetevents.com. An online replay will be available shortly after the call at these sites.

About Curative Health Services

Curative Health Services' Specialty Healthcare Services (SHS) business unit is a leading disease management company. The SHS unit is the undisputed industry leader in chronic wound care management, consistently achieving an outcome success rate of more than 80 percent, more than twice the industry average. Curative provides a broad continuum of services to health care providers through a nationwide network. This national network of more than 110 hospital-based Care Centers in 33 states, has offered comprehensive treatment to over 300,000 patients, achieving more than a 95 percent patient satisfaction rate.

About eBioCare

eBioCare, Curative Health Services' Specialty Pharmacy Services (SPS) business unit, provides "high touch," patient centric services to patients, physicians and others that facilitate the health care management process. These include services such as direct-to-patient overnight distribution of biopharmaceuticals, medication management, and a comprehensive resource of chronic condition medical information.

For more information, visit www.curative.com

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Factors that might cause such differences include, but are not limited to, the termination or non-renewal of a material number of contracts, an inability to obtain new contracts, changes in the government regulations relating to the Company's wound care operations or the operations of eBioCare, changes in the regulations governing third party reimbursements for Curative services, manufacturing shortages of products sold by eBioCare, and the other risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission. Readers of this press release are referred to the Company's Annual Report on Form 10-K for the year ended December 31, 2000 for further discussion of these and other factors that could affect future results.